Current evidence suggests GLP-1 receptor agonists may have immunomodulatory properties, but no robust clinical trial data confirms they treat primary autoimmune diseases
Wegovy is not indicated for people under 18, those with type 1 diabetes, or during pregnancy and breastfeeding
Establishing national PD registries, integrating PD into noncommunicable disease (NCD) strategies, and investing in mobile health screening tools are critical steps toward improved surveillance and resource allocation
About the Diets People Always Bring Up Yes, Ive done low-carb
5-8 Clinical trials confirmed blood sugar benefits and showed that these medications also reduce risk of cardiovascular events in diabetics, including heart attack and stroke, by as much as 26%
Fueling this ongoing conversation is a recent, How to Get Zepbound Covered by Insurance (and Save Money) Getting cost effective access to a new medication like Zepbound (tirzepatide) can feel overwhelming